Fully Substitutable and Chemically Equivalent*
Fresenius Kabi’s FDA-approved generic Icatibant Injection offers patients an affordable, fully substitutable, chemically equivalent* option in treating acute attacks of Hereditary angioedema (HAE). Icatibant Injection is indicated for the treatment of acute attacks of (HAE) in adults 18 years of age and older.
Convenient, on-demand treatment gives you the confidence you need to live freely, knowing you have a medicine you can use at the first signs of HAE symptoms.
Talk to your doctor to see if Icatibant Injection is the right on-demand treatment for you.
Icatibant Injection treats all types of acute HAE attacks, including skin (cutaneous), stomach (abdominal), and throat (laryngeal).
The package and pre-filled syringe are convenient and easy to use whether you’re at home or on-the-go. Icatibant Injection can be used both in and out of the home—after training by a healthcare professional.
There is no way to predict with 100% certainty when an attack will occur, where in the body it will occur, or how severe it will be. Even if your attack is a mild one, Icatibant Injection can reduce the length of time the attack lasts.3,11
If your symptoms continue or come back, you may repeat your Icatibant Injection at least six hours apart. Do not use more than 3 doses in 24 hours.11
If you have a laryngeal (throat) attack, inject Icatibant Injection and then go to the nearest hospital emergency room right away.